Trials / Completed
CompletedNCT00570141
OASIS Wound Matrix (Oasis) Mechanism of Action
Case Study Documentation of Subjects With Either Diabetic Foot Ulcers or Venous Stasis Ulcers Being Treated With OASIS
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Healthpoint · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
OASIS Wound Matrix (Oasis) will be applied to wounds, with sequential biopsy of healing wounds to explore the mechanism of action.
Detailed description
Wound types will be Diabetic Foot Ulcers (DFU) and Venous Stasis Ulcers (VSU).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OASIS Wound Matrix | OASIS (an acellular biomaterial that supports tissue repair with a scaffold-like matrix having a natural structure and composition). |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-04-01
- Completion
- 2010-04-01
- First posted
- 2007-12-10
- Last updated
- 2011-06-09
- Results posted
- 2010-08-09
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00570141. Inclusion in this directory is not an endorsement.